| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $43.6M | -30.9% |
| SG&A Expense | $17.7M | -18.8% |
| Operating Income | -$59.3M | +19.8% |
| Income Tax | $0 | — |
| Net Income | -$59.6M | +14.6% |
| EPS (Basic) | -$1.01 | +29.9% |
| EPS (Diluted) | -$1.01 | +29.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -85.5% |
| Current Assets | $8.0M | -84.4% |
| Total Assets | $13.8M | -73.6% |
| Current Liabilities | $21.9M | +50.8% |
| Total Liabilities | $50.0M | +31.1% |
| Stockholders' Equity | -$36.2M | -353.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.2M | +33.0% |
| Financing Cash Flow | $6.3M | -34.0% |